journal
https://read.qxmd.com/read/38720132/distribution-of-nosocomial-pathogens-and-antimicrobial-resistance-among-patients-with-burn-injuries-in-china-a-comprehensive-research-synopsis-and-meta-analysis
#21
JOURNAL ARTICLE
Yuhui Yang, Qingling Zeng, Guangyun Hu, Zhenkun Wang, Zongyue Chen, Lang Zhou, Aibo He, Wei Qian, Yu Luo, Gaoming Li
INTRODUCTION: Over the past decade, numerous studies have described the types of pathogens and their antibiotic resistance patterns in patients with burn injuries in China; however, the findings have generally been inconsistent. We conducted a literature search and meta-analysis to summarize the infection spectra and antimicrobial resistance patterns in patients with burn injuries. METHODS: We searched the PubMed, Embase, Web of Science, China National Knowledge Infrastructure, China Biomedical Literature, Wanfang, and Weipu databases for relevant articles published between January 2010 and December 2023...
May 9, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38713301/penetration-profile-of-terbinafine-compared-to-amorolfine-in-mycotic-human-toenails-quantified-by-matrix-assisted-laser-desorption-ionization-fourier-transform-ion-cyclotron-resonance-imaging
#22
JOURNAL ARTICLE
Nicolas Joly-Tonetti, Raphael Legouffe, Aurore Tomezyk, Clémence Gumez, Mathieu Gaudin, David Bonnel, Martin Schaller
INTRODUCTION: Amorolfine 5% lacquer is an established topical treatment for fungal infection of the nails. The success of topical therapy for onychomycosis depends on whether the permeated drug concentration in the deep nail bed is retained above the effective antifungal minimum inhibitory concentration (MIC). We compared the penetration profile of amorolfine and a new topical formula of terbinafine in human mycotic toenails using matrix-assisted laser desorption ionization mass spectrometry imaging-Fourier transform ion cyclotron resonance (MALDI-FTICR) imaging...
May 7, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38789901/respiratory-syncytial-virus-sequelae-among-adults-in-high-income-countries-a-systematic-literature-review-and-meta-analysis
#23
REVIEW
Egbe Ubamadu, Estefania Betancur, Bradford D Gessner, Sonia Menon, Hilde Vroling, Daniel Curcio, Mark Rozenbaum, Samantha K Kurosky, Zuleika Aponte, Elizabeth Begier
INTRODUCTION: Respiratory syncytial virus (RSV) can cause severe respiratory infections in adults; however, information on associated sequelae is limited. This systematic literature review aimed to identify sequelae in adults within 1 year following RSV-related hospitalization or resolution of acute infection. METHODS: Studies were identified from Embase, MEDLINE, LILACS, SciELO, and grey literature. Random-effects meta-analyses using restricted maximum likelihood were used to calculate the proportions and relative risks of sequelae in patients with RSV compared with controls (patients with RSV-negative influenza-like illness, influenza, and parainfluenza) per follow-up period, population, and treatment setting, where possible...
May 6, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38704491/penetration-profiles-of-four-topical-antifungals-in-mycotic-human-toenails-quantified-by-matrix-assisted-laser-desorption-ionization-fourier-transform-ion-cyclotron-resonance-imaging
#24
JOURNAL ARTICLE
Nicolas Joly-Tonetti, Raphael Legouffe, Aurore Tomezyk, Clémence Gumez, Mathieu Gaudin, David Bonnel, Martin Schaller
INTRODUCTION: Onychomycosis is a fungal infection of the nails that can be challenging to treat. Here, matrix-assisted laser desorption ionization-Fourier transform ion cyclotron resonance (MALDI-FTICR) imaging was applied to the quantitative analysis of the penetration profile of the antifungal compound, amorolfine, in human mycotic toenails. The amorolfine profile was compared with those of three other antifungals, ciclopirox, naftifine, and tioconazole. METHODS: Antifungal compounds (amorolfine 5% lacquer, ciclopirox 8% lacquer, naftifine 1% solution, and tioconazole 28% solution) were applied to mycotic nails (n = 42)...
May 4, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38703336/efficacy-safety-and-pharmacokinetics-of-azd7442-tixagevimab-cilgavimab-for-prevention-of-symptomatic-covid-19-15-month-final-analysis-of-the-provent-and-storm-chaser-trials
#25
JOURNAL ARTICLE
Myron J Levin, Andrew Ustianowski, Stephane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, Kanika Dey, Karen A Near, Katie Streicher, Alexandre Kiazand, Mark T Esser
INTRODUCTION: The phase 3 PROVENT and STORM CHASER studies evaluated AZD7442 (tixagevimab/cilgavimab) for pre-exposure and post-exposure prophylaxis of symptomatic coronavirus disease 2019 (COVID-19). We report the final 15-month results of both studies. METHODS: In PROVENT, participants were randomized 2:1 to receive 300 mg AZD7442 (n = 3460) or placebo (n = 1737). In STORM CHASER, participants were enrolled within 8 days of exposure to a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individual and randomized 2:1 to receive 300 mg AZD7442 (n = 749) or placebo (n = 372)...
May 4, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38700655/cost-effectiveness-of-20-valent-pneumococcal-conjugate-vaccine-in-argentinean-adults
#26
JOURNAL ARTICLE
Lucila Rey-Ares, Ahuva Averin, Mercedes Mac Mullen, Dhwani Hariharan, Mark Atwood, Carolina Carballo, Liping Huang
INTRODUCTION: In Argentina, vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23; PCV13 → PPSV23) has been recommended for all adults aged ≥ 65 years and younger adults with chronic medical ("moderate-risk") or immunocompromising ("high-risk") conditions since 2017. With the approval of a 20-valent PCV (PCV20), we evaluated the cost-effectiveness of PCV20 versus current recommendations for moderate-/high-risk adults aged 18-64 years and all adults 65-99 years...
May 3, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38700654/nasal-staphylococcus-aureus-carriage-and-antimicrobial-resistance-profiles-among-community-dwelling-adults-in-jiangsu-china
#27
JOURNAL ARTICLE
Wenjing Hu, Yang Wang, Lu Zhou, Kai Chu, Pengfei Jin, Qi Liang, Jingxin Li, Zhongming Tan, Fengcai Zhu
INTRODUCTION: Persistent nasal carriage has been associated with Staphylococcus aureus infection. Previous S. aureus studies in Asia have primarily focused on clinical patients, providing limited information on persistent nasal carriage among the general adult population. METHODS: This study examined 143 healthy adults in a community in Jiangsu, China. Nasal swab samples were collected 10 times. The colonization status was identified using SPA typing...
May 3, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38679663/real-world-efficacy-and-safety-of-universal-8-week-glecaprevir-pibrentasvir-for-treatment-na%C3%A3-ve-patients-from-a-nationwide-hcv-registry-in-taiwan
#28
JOURNAL ARTICLE
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Hsing-Tao Kuo, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
INTRODUCTION: Eight-week glecaprevir/pibrentasvir (GLE/PIB) is indicated for treatment-naïve (TN) patients with chronic hepatitis C (CHC), with or without compensated cirrhosis. Given that the Taiwanese government is committed to eliminating hepatitis C virus (HCV) by 2025, this study aimed to measure real-world evidence for TN patients using 8-week GLE/PIB in the Taiwan HCV Registry (TACR). METHODS: The data of patients with CHC treated with 8-week GLE/PIB were retrieved from TACR, a nationwide registry program organized by the Taiwan Association for the Study of the Liver (TASL)...
April 28, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38662333/correction-to-virologic-outcomes-with-molnupiravir-in-nonhospitalized-adult-patients-with-covid-19-from-the-randomized-placebo-controlled-move-out-trial
#29
Julie M Strizki, Jay A Grobler, Nicholas Murgolo, Arthur Fridman, Matthew G Johnson, Jiejun Du, Patricia Carmelitano, Michelle L Brown, Amanda Paschke, Carisa De Anda
No abstract text is available yet for this article.
April 25, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38662332/burden-of-antimicrobial-resistance-in-japan-a-systematic-literature-review-and-meta-analysis
#30
JOURNAL ARTICLE
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto
INTRODUCTION: Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. However, there is limited evidence assessing the AMR burden in Japan. Thus, this systematic literature review (SLR) and meta-analysis (MA) were conducted to assess the clinical and economic burden of AMR in Japan. METHODS: Comprehensive literature searches were performed on EMBASE, MEDLINE, the Cochrane Library, and ICHUSHI between 2012 and 2022 following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines...
April 25, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38662331/modelling-covid-19-vaccination-in-the-uk-impact-of-the-autumn-2022-and-spring-2023-booster-campaigns
#31
JOURNAL ARTICLE
Diana Mendes, Sheeja Machira Krishnan, Esmé O'Brien, Thomas Padgett, Cale Harrison, W David Strain, Andrea Manca, Andrew Ustianowski, Rebecca Butfield, Elizabeth Hamson, Charlie Reynard, Jingyan Yang
INTRODUCTION: The delivery of COVID-19 vaccines was successful in reducing hospitalizations and mortality. However, emergence of the Omicron variant resulted in increased virus transmissibility. Consequently, booster vaccination programs were initiated to decrease the risk of severe disease and death among vulnerable members of the population. This study aimed to estimate the effects of the booster program and alternative vaccination strategies on morbidity and mortality due to COVID-19 in the UK...
April 25, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38656653/systematic-literature-review-on-the-incidence-of-herpes-zoster-in-populations-at-increased-risk-of-disease-in-the-eu-eea-switzerland-and-the-uk
#32
JOURNAL ARTICLE
Alen Marijam, Nikki Vroom, Amit Bhavsar, Inga Posiuniene, Nicolas Lecrenier, Hilde Vroling
INTRODUCTION: Older adults and patients with underlying conditions such as immunocompromised (IC) populations (e.g., due to medical conditions or immunosuppressive medication) are at increased risk for herpes zoster (HZ). The first HZ recombinant vaccine for IC patients was approved in 2020. Limited evidence exists to inform decision-makers on HZ incidence in high-risk patients in Europe. This systematic literature review (SLR) assessed HZ incidence across 14 high-risk populations in the European Union/European Economic Area, Switzerland, and the United Kingdom...
April 24, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38643431/prognostic-significance-of-nlr-and-plr-in-covid-19-a-multi-cohort-validation-study
#33
JOURNAL ARTICLE
Marta Colaneri, Camilla Genovese, Federico Fassio, Marta Canuti, Andrea Giacomelli, Anna Lisa Ridolfo, Erika Asperges, Giuseppe Albi, Raffaele Bruno, Spinello Antinori, Antonio Muscatello, Bianca Mariani, Ciro Canetta, Francesco Blasi, Alessandra Bandera, Andrea Gori
INTRODUCTION: Recent studies have highlighted the prognostic value of easily accessible inflammatory markers, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for predicting severe outcomes in patients affected by Coronavirus disease 2019 (COVID-19). Our study validates NLR and PLR cut-off values from a prior cohort at IRCCS Policlinico San Matteo (OSM) of Pavia, Italy, across two new cohorts from different hospitals. This aims to enhance the generalizability of these prognostic indicators...
April 21, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38642238/underlying-neural-mechanisms-of-cognitive-improvement-in-fronto-striatal-response-inhibition-in-people-living-with-hiv-switching-off-efavirenz-a-randomized-controlled-bold-fmri-trial
#34
JOURNAL ARTICLE
Patrick G A Oomen, Charlotte S Hakkers, Joop E Arends, Guido E L van der Berk, Pascal Pas, Andy I M Hoepelman, Berend J van Welzen, Stefan du Plessis
INTRODUCTION: It is unclear whether neurotoxicity due to the antiretroviral drug efavirenz (EFV) results in neurocognitive impairment in people living with HIV (PLWH). Previously, we found that discontinuing EFV was associated with improved processing speed and attention on neuropsychological assessment. In this imaging study, we investigate potential neural mechanisms underlying this cognitive improvement using a BOLD fMRI task assessing cortical and subcortical functioning. METHODS: Asymptomatic adult PLWH stable on emtricitabine/tenofovirdisoproxil/efavirenz were randomly (1:2) assigned to continue their regimen (n = 12) or to switch to emtricitabine/tenofovirdisoproxil/rilpivirine (n = 28)...
April 20, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38613628/fungal-prosthetic-joint-infection-a-case-series-and-review-of-the-literature
#35
JOURNAL ARTICLE
Victoria Starnes, Joan Duggan, Caitlyn Hollingshead
INTRODUCTION: Fungal prosthetic joint infections comprise less than 1% of prosthetic joint infections. Thus, little is known regarding optimal management. This study aims to characterize the microbiology, surgical and medical management, and outcomes for these complex infections. The objectives of this study were to assess the impact of surgical approach, antifungal treatment, fungal species, and time to onset of infection from initial surgery on patient outcomes. METHODS: A retrospective record review over 12 years was performed in two health systems that included patients with a deep culture positive for a fungal isolate and the presence of a prosthetic joint...
April 13, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38609668/ritonavir-25-years-experience-of-concomitant-medication-management-a-narrative-review
#36
REVIEW
Romina Quercia, Giovanni Di Perri, Carolina Pein, Jennifer Bodie, Ravi Shankar P Singh, Victoria Hendrick, Marta Boffito
Ritonavir is a potent inhibitor of the cytochrome P450 3A4 enzyme and is commonly used as a pharmacokinetic (PK) enhancer in antiviral therapies because it increases bioavailability of concomitantly administered antivirals. Decades of experience with ritonavir-enhanced HIV therapies and, more recently, COVID-19 therapies demonstrate that boosting doses of ritonavir are well tolerated, with an established safety profile. The mechanisms of PK enhancement by ritonavir result in the potential for drug-drug interactions (DDIs) with several classes of drugs, thus making co-medication management an important consideration with enhanced antiviral therapies...
April 12, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38607524/effect-of-regdanvimab-on-mortality-in-patients-infected-with-sars-cov-2-delta-variants-a-propensity-score-matched-cohort-study
#37
JOURNAL ARTICLE
Soyoon Hwang, Nan Young Lee, Eunkyung Nam, Yu Kyung Kim, Shin-Woo Kim, Hyun-Ha Chang, Yoonjung Kim, Sohyun Bae, Juhwan Jeong, Jae-Ho Shin, Guehwan Jang, Changhee Lee, Ki Tae Kwon
INTRODUCTION: Regdanvimab, a monoclonal antibody pharmaceutical, is the first Korean drug approved for treating coronavirus disease 2019 (COVID-19). We analyzed the therapeutic efficacy of regdanvimab in patients with the COVID-19 delta variant infection. METHODS: We retrospectively reviewed the electronic medical records of patients hospitalized at two Korean tertiary COVID-19 hospitals with COVID-19 delta variant infection between May 26, 2021, and January 30, 2022...
April 12, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38589762/systematic-review-of-heel-puncture-related-osteomyelitis-of-the-calcaneus-in-newborn-infants
#38
REVIEW
Vidmi Taolam Martin, Ismail Ahmed Dhagey, Hangtian Wu, Shaoyong Xu, Bin Yu
INTRODUCTION: Heel puncture (HP) in neonates can result in osteomyelitis if done non-aseptically or with incorrect technique. This study summarizes clinical experience with heel puncture-related osteomyelitis of the calcaneus (HP-CO) in newborns. METHODS: We systematically reviewed studies that examined HP-CO in newborn patients using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Our search included the PubMed, Embase, and Cochrane Library databases until December 31, 2023...
April 8, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38578515/seroprevalence-and-shifting-endemicities-of-hepatitis-a-virus-infection-in-two-different-geographical-areas-in-the-philippines
#39
JOURNAL ARTICLE
Josefina C Carlos, Vinna Marie T Quinones, Maria Peñafrancia L Adversario, Jennifer M Nailes, Jangail C Songco, Donaliz R Garcia, Michelle G Cacayorin, May Priscilla V Cero, Maria Paula Aleta Benedicto-Delfin, Ma Christina C Blanco, Nadjah S Natividad, Jacqueline D Bernabe, Hyacinth Claire T Chacon, Ronald Alvin C Ascue, Jayme Natasha K Paggao, Lous Ohsana P Comendador, Gustavo Hernandez-Suarez, Adriana Guzman-Holst
INTRODUCTION: Infection with hepatitis A virus (HAV) is often asymptomatic in young children, but most adolescents and adults will have symptoms ranging from nausea and tiredness to acute liver failure and even death. The risk of severe disease is higher in older adults and people with pre-existing liver disease. Immunization is recommended in regions with low HAV endemicity levels, i.e., where people get infected later in life. In the Philippines, recent epidemiologic data on HAV infection are lacking...
April 5, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38570446/modelling-the-public-health-impact-of-menacwy-and-menc-adolescent-vaccination-strategies-in-germany
#40
JOURNAL ARTICLE
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Scholz, Wolfgang Greiner, Oliver Damm
INTRODUCTION: Invasive meningococcal disease (IMD) causes significant mortality and long-term sequelae. This study assesses the potential public health impact of adolescent vaccination strategies employing MenACWY and MenC vaccines in Germany, where the existing meningococcal immunisation programme predominantly involves MenC administration in toddlers. METHODS: A dynamic transmission model was developed to simulate the carriage of five meningococcal serogroup compartments (AY/B/C/W/Other) from 2019 until 2060 within 1-year age groups from 0 to 99 years of age...
April 4, 2024: Infectious Diseases and Therapy
journal
journal
48936
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.